10-Q
Quarterly Report
VITASPRING BIOMEDICAL CO., LTD.
CIK: 1697884
File #: 333-216645
Balance Sheet
28 line items · 2 periods
XBRL
| Item | Apr 30, 2026 | Jan 31, 2026 |
|---|---|---|
BALANCE SHEETS | ||
ASSETS | ||
CURRENT ASSETS | ||
Cash | 8,167 | 2,084 |
Other Non-Operating Current Assets | 1,605 | 8,443 |
Total current assets | 9,772 | 10,527 |
LONG-TERM ASSET | ||
Property, Plant and Equipment | 1,660 | 4,149 |
Total long-term asset | 1,660 | 4,149 |
Total assets | 11,432 | 14,676 |
LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
CURRENT LIABILITIES | ||
Accounts payable - related party | 2,411,000 | 2,411,000 |
Other Non-Operating Current Liabilities | 711,641 | 652,027 |
Taxes Payable | 342,852 | 344,234 |
Advances from related party | 1,052,351 | 1,037,983 |
Total current liabilities | 4,517,844 | 4,445,244 |
Total liabilities | 4,517,844 | 4,445,244 |
COMMITMENTS AND CONTINGENCIES | 0 | 0 |
STOCKHOLDERS' DEFICIT | ||
Total Stockholders' Equity | 20,703 | 20,703 |
Total Stockholders' Equity | 1,245,600 | 1,245,600 |
Total Stockholders' Equity | (5,772,715) | (5,696,871) |
Total stockholders' deficit | (4,506,412) | (4,430,568) |
Retained Earnings (Accumulated Deficit) | (5,772,715) | (5,696,871) |
Additional Paid-In Capital | 1,245,600 | 1,245,600 |
Common Stock | 20,703 | 20,703 |
Total liabilities and stockholders' deficit | 11,432 | 14,676 |